Host Karen Tkaczyk sits down with Sara Brueck Nichols, President of McCreadie Group, for a Life Sciences – In Focus Podcast episode that moves seamlessly between personal experience, industry insight, and practical innovation.
A Defining Origin Story
Sara’s path into life sciences was not linear, but it was deeply personal. As a high school student, a routine surgery led to a severe medication interaction that left her temporarily paralyzed and bedridden for weeks. Instead of simply catching up on missed coursework, she was given an unusual assignment: understand what had happened to her.
That experience became a turning point.
Spending hours in hospital libraries, researching pharmacology and physiology, Sara developed both a fascination with healthcare and a sense of empowerment through knowledge. Although her early academic path diverged, she ultimately returned to that foundation, building a career that bridges healthcare, technology, and operations.
Today, with over two decades in healthcare technology, that early experience continues to shape her perspective. The patient is never an abstraction; it is the starting point.
What McCreadie Group Does Differently
At McCreadie Group, Sara leads a company focused on solving a very specific, often overlooked challenge in clinical research: operational complexity in research pharmacies.
Their core platform, Vestigo, is designed as a compliance-first system to manage protocols, streamline workflows, and reduce risk in complex research environments. What sets the company apart is not just the technology itself, but how it is built and supported.
The platform was originally developed by a research pharmacist who was also a computer scientist. That dual perspective remains embedded in the organization today:
- Product teams include pharmacists and clinicians
- Customer support is staffed by professionals with real clinical trial experience
- Workflows are designed based on real-world usage, not theoretical models
This grounding in practice allows the platform to address the nuances that generic technology solutions often miss. It is not technology adapted to healthcare; it is technology born from it.
The impact is measurable. Sara highlights outcomes such as significant reductions in documentation time and strong revenue growth for users, both indicators of improved operational efficiency.
The State of Clinical Research in 2026
The conversation then widens to the broader landscape of clinical research, which Sara describes as being at an inflection point.
Several major shifts are underway:
1. Globalization is Accelerating The United States no longer dominates clinical research. Countries such as China, the UK, EU nations, Australia, and India are playing increasingly significant roles.This shift brings clear benefits:
- More diverse patient populations
- Better data quality
- Greater global relevance of trial outcomes
However, it also introduces complexity, particularly in regulatory alignment, language requirements, and operational coordination.
2. Protocol Complexity is Rising A growing proportion of clinical trials are now classified as complex. Alongside this, the number of protocol amendments continues to increase. Each amendment has cascading effects:- Additional documentation
- Increased administrative burden
- Delays in timelines
- Higher costs Complexity, in other words, is no longer the exception; it is the norm. 3. Legacy Processes Are Holding the Industry Back
- Data handling becomes inefficient
- Version control becomes difficult
- Collaboration slows down
- Compliance risks increase
- Repeated manual steps
- Fragmented systems requiring multiple logins
- Poorly documented processes
- Redundant data entry
- Inefficient training and onboarding
- Increased cognitive load for staff
- Higher risk of errors
- Reduced efficiency
- Frustration and burnout
- She sees the current moment as one of the greatest opportunities the industry has faced in decades. Several factors are aligning:
- Regulatory bodies are actively seeking to streamline processes
- Sponsors and sites share common goals around efficiency
- Technology is mature enough to support meaningful change
- There is a growing willingness to collaborate across stakeholders
Despite being a cutting-edge scientific field, clinical research remains heavily dependent on paper-based processes, whether physical or digital.
This reliance creates friction at every stage:
For Sara, this disconnect is one of the most urgent problems to solve.
The Hidden Threat: “Micro-Leaks” in Clinical Operations
One of the most compelling ideas discussed in the episode is the concept of “micro-leaks.”
These are small inefficiencies embedded within workflows that, individually, seem insignificant but collectively have a substantial impact.
Each of these adds seconds or minutes to a task. Across teams, studies, and timelines, they translate into hours, then into financial loss, then into delayed outcomes.
In a field where speed can directly affect patient access to treatment, these inefficiencies matter.
Sara draws parallels to manufacturing principles, such as workflow optimization and process design. The same discipline applied in industrial settings must now be rigorously applied in clinical research.
Technology Fatigue and Fragmentation
Another challenge facing research sites is what Sara describes as technology fatigue.
Sites are often required to use multiple platforms across different sponsors, each with its own interface, login, and workflow. These systems rarely integrate seamlessly.
The result is:
Even the simple act of logging into multiple systems becomes a micro-leak. Over time, these inefficiencies accumulate into measurable operational drag.
A Turning Point for the Industry
Despite these challenges, Sara is optimistic.
The key, however, lies in mindset.
Progress will require organizations to move beyond familiar but inefficient processes. It will require letting go of legacy systems and habits that no longer serve the industry’s needs. That shift is not purely technical; it is cultural.
Bringing It Back to the Patient
Sara returns to a central theme: the patient.
Every improvement in workflow, every reduction in inefficiency, every advancement in technology ultimately serves a single purpose: improving patient outcomes.
Her own experience as a patient continues to inform her work. It provides a constant reminder that behind every protocol, every dataset, and every system is a human life.
That perspective anchors the conversation in something tangible and urgent.
About Life Sciences – In Focus
Life Sciences – In Focus Podcast by Visatatec, a fascinating conversation with global life sciences experts. The show has multiple hosts and topics. Follow Life Sciences – In Focus on Spotify for all the latest episodes, or subscribe to the show on YouTube and Apple podcasts. Life Sciences – In Focus is available on many other podcast platforms. To learn more about the podcast, please visit https://vistatec.com/life-sciences-division.
About Vistatec
We have been helping some of the world’s most iconic brands to optimize their global commercial potential since 1997. Vistatec is one of the world’s leading global content solutions providers. HQ in Dublin, Ireland, with offices in Mountain View, California, USA. To learn more about Vistatec, please visit https://www.vistatec.com
